* STRATA Skin Sciences Inc SSKN.OQ SSKN.O is expected
to show
a rise in quarterly revenue when it reports results on May 15.
* The Horsham Pennsylvania-based company is expected to
report a
39.0% increase in revenue to $9.784 million from $7.04 million a
year ago, according to the mean estimate from 2 analysts, based
on Refinitiv data.
* Refinitiv's mean analyst estimate for STRATA Skin
Sciences Inc
is for a loss of 7 cents per share.
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts had fallen by
about 6.8%
in the last three months.
* Wall Street's median 12-month price target for STRATA Skin
Sciences Inc is $5.25, above its last closing price of $1.03.
This summary was machine generated May 12 at 23:11 GMT. All
figures in US dollars unless otherwise stated